These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 14695103)

  • 1. Sildenafil for pulmonary arterial hypertension: still waiting for evidence.
    Humbert M; Simonneau G
    Am J Respir Crit Care Med; 2004 Jan; 169(1):6-7. PubMed ID: 14695103
    [No Abstract]   [Full Text] [Related]  

  • 2. Advancing therapy for pulmonary arterial hypertension: can animal models help?
    Robbins IM
    Am J Respir Crit Care Med; 2004 Jan; 169(1):5-6. PubMed ID: 14695102
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Liu H; Liu ZY; Guan Q
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
    Zeng Z; Li Y; Jiang Z; Wang C; Li B; Jiang W
    Cardiovasc Ther; 2010; 28(1):23-9. PubMed ID: 20074256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Yilmaz H; Butrous G; Ermert L; Ermert M; Weissmann N; Rose F; Guenther A; Walmrath D; Seeger W; Grimminger F
    Am J Respir Crit Care Med; 2004 Jan; 169(1):39-45. PubMed ID: 12958054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
    Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
    Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of sildenafil in primary pulmonary hypertension.
    Oudiz RJ; Wasserman K
    J Am Coll Cardiol; 2004 Dec; 44(11):2256; author reply 2256-7. PubMed ID: 15582332
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

  • 9. Viagra eases symptoms of pulmonary arterial hypertension in children.
    Senior K
    Drug Discov Today; 2005 Oct; 10(20):1337. PubMed ID: 16253866
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension.
    Dias-Junior CA; Souza-Costa DC; Zerbini T; da Rocha JB; Gerlach RF; Tanus-Santos JE
    Anesth Analg; 2005 Jul; 101(1):115-20, table of contents. PubMed ID: 15976216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil for pulmonary arterial hypertension complicating respiratory disease.
    Aggarwal AN
    Indian J Chest Dis Allied Sci; 2008; 50(4):317-9. PubMed ID: 19035049
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension].
    Wodniecki J; Jacheć W; Poloński L; Tomasik AR; Wojciechowska C; Foremny A
    Przegl Lek; 2005; 62(2):135-8. PubMed ID: 16095162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats.
    Dai ZK; Tan MS; Chai CY; Chou SH; Lin PC; Yeh JL; Jeng AY; Chang CI; Chen IJ; Wu JR
    Exp Biol Med (Maywood); 2006 Jun; 231(6):942-7. PubMed ID: 16741028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil for primary and secondary pulmonary hypertension.
    Watanabe H; Ohashi K; Takeuchi K; Yamashita K; Yokoyama T; Tran QK; Satoh H; Terada H; Ohashi H; Hayashi H
    Clin Pharmacol Ther; 2002 May; 71(5):398-402. PubMed ID: 12011826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling.
    Yen CH; Leu S; Lin YC; Kao YH; Chang LT; Chua S; Fu M; Wu CJ; Sun CK; Yip HK
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):574-84. PubMed ID: 20224427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease.
    Montgomery GS; Sagel SD; Taylor AL; Abman SH
    Pediatr Pulmonol; 2006 Apr; 41(4):383-5. PubMed ID: 16479610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension.
    van Wolferen SA; Boonstra A; Marcus JT; Marques KM; Bronzwaer JG; Postmus PE; Vonk-Noordegraaf A
    Heart; 2006 Dec; 92(12):1860-1. PubMed ID: 17105892
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension.
    Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG
    J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.